Introduction
============

Since the first ice-free cryopreservation of mouse embryos by vitrification \[[@B1]\], many studies have helped to simplify and shorten the cryopreservation procedure. The vitrification of human embryos has been extensively tested and is now a routine technique in assisted reproduction laboratories \[[@B2]\]. Among the variety of procedures used to cryopreserve embryos, a hand-made container called a pull and cut straw (PNC) has recently been reported \[[@B3]\]. Studies indicate that PNC is useful for the vitrification of human blastocysts and cleavage-stage embryos. The technique also has the benefits of simplicity, cost-efficiency and rapid cooling \[[@B4]\].

It is well known that damage caused by freezing is an important factor influencing the quality of embryos. Such damage induces zona hardening, delays embryo development and perturbs zona pellucida morphology, reducing the ability of embryos to hatch and implant \[[@B5]-[@B7]\]. Another cause of reducing the ability of embryos is transfer of partial lysed embryos \[[@B8]\]. A previous studies reported that clinical pregnancy and implantation rates were significantly increased after zona drilling of frozen embryos or removing of lysed blastomeres in vitrified and warmed embryos \[[@B9]-[@B11]\]. However, another study found that assisted hatching (AH) treatment of embryos from both human and animal models has no effects on embryo development and pregnancy \[[@B12]\]. Many *in vitro* fertilization (IVF) centers now perform AH procedures for infertility patients in the hope of increasing the chance of each embryo successfully hatching and implanting. Therefore, detailed investigations into the effects of AH on the embryo under specific conditions and/or developmental stages may offer valuable information to the human IVF/embryo transfer (ET) program.

In this study, we describe PNC and compare the rates of embryo survival and clinical pregnancy of vitrified-warmed embryos using PNC and conventional 0.25 mL straw containers. In addition, we investigated the pregnancy rate of vitrified-warmed human cleavage-stage embryos and blastocysts with AH treatment.

Materials and methods
=====================

1. Patients
-----------

Couples entered the IVF-ET program for infertility treatment either because of male factors (intracytoplasmic sperm injection \[ICSI\] with ejaculate, epididymal or testicular sperm) and/or female factors (tubal, endometriosis or idiopathic). Vitrified-warmed embryos were transferred into women whose ages ranged from 23 to 46 years after being cultured in medium ([Table 1](#T1){ref-type="table"}). Vitrification was performed using supernumerary embryos that had reached cleaved embryo stage after 3 days and blastocyst stage after five days of culture.

2. Superovulation and collection of oocytes
-------------------------------------------

Ovarian stimulation was performed using urinary follicle-stimulating hormone (FSH, highly purified-FSH, Serono, Geneva, Switzerland), recombinant FSH (Gonal F, Merck-Serono, Darmstadt, Germany) or hMG (Pergona, Serono, Switzerland; Merional, IBSA, Lugano, Switzerland) in combination with a gonadotropin-releasing hormone (GnRH) antagonist (Cetrotide, Merck-Serono, Germany) or agonist (Suprefact, Aventis Pharma, Frankfurt, Germany). Oocyte maturation was induced by injection of 10,000 IU human chorionic gonadotropin (hCG; IVF-C, LG, Seoul, Korea; choriomon, IBSA, Switzerland or Profasi, Merck-Serono, Geneva, Switzerland) as soon as three follicles with a size of 18 mm were observed by ultrasound. Oocytes were retrieved 36 hours after hCG administeration using vaginal ultrasound-guided puncture of ovarian follicles.

3. Fertilization of oocytes and culture of zygotes
--------------------------------------------------

Collected oocytes were cultured in P1 media (Irvine Scientific, Irvine, CA, USA) supplemented with 10% synthetic serum substitute (SSS) (Irvine Scientific) for 3 to 4 hours. In preparation for ICSI, cumulus and corona cells were removed from the oocyte and the cumulus complex using HTF media (Irvine Scientific) supplemented with 100 IU/mL hyaluronidase (Type VIII, Sigma Chemical Co., St. Louis, MO, USA). Following ICSI, oocytes were cultured in P1 media supplemented with 10% SSS for 18 hours. The zygotes obtained by this procedure were selected on the basis of their morphology and formation of nucleus which showed two pronuclei and second polar body then were cultured for a further 48 hours. Embryos remaining after embryo transfer were vitrified or sequentially cultured in G2 Medium (Vitrolife AB, Kungsbacka, Sweden) for three days until they developed into blastocysts then vitrified.

4. Vitrification of cleavage embryos and blastocysts
----------------------------------------------------

Vitrification of embryos and blastocysts was performed using two containers: a PNC vessel and a conventional 0.25 mL straw \[[@B3]\]. During conventional 0.25 mL straw vitrification, blastocysts were incubated in 10% glycerol in Dulbecco\'s phosphate buffered saline (DPBS, Gibco, Grans Island, NY, USA) for 5 minutes, transferred to 10% glycerol, 20% ethylene glycol (Sigma-Aldrich) in DPBS for 5 minutes and finally transferred to 25% glycerol, 25% ethylene glycol in DPBS for 1 minute. Blastocysts were then loaded as described by Schiewe et al. \[[@B13]\]. Briefly, the following components were placed in the following order into a 0.25 mL plastic straw: 6 cm column of 1 M sucrose in DPBS; 0.5 cm air space; 0.5 cm of vitrification solution (25% ethylene glycol, 25% glycerol, 0.5 M sucrose and 10% (v/v) SSS in DBPS); 0.5 cm air space; 1 cm of vitrification solution with embryos. The straw was then plunged into liquid nitrogen for storage ([Fig. 1](#F1){ref-type="fig"}).

For the vitrification of cleavage embryos and blastocysts using PNC, embryos and blastocysts were incubated in 7.5% ethylene glycol, 7.5% DMSO (Sigma-Aldrich) and 10% (v/v) SSS in DBPS for 15 minutes and were then transferred to vitrification solution (15% ethylene glycol, 15% DMSO, 0.5 M sucrose in DPBS) for 1 minute. Briefly, the PNC container was constructed by heating the middle part of a standard 0.25 mL insemination straw, which was then molded to achieve an inner diameter of 0.1 mm and then cut at a 45° angle. Embryos and blastocysts were loaded onto the edge of the PNC in less than 1 µL of vitrification solution and were then covered with the remaining part of the straw. The PNC was then plunged into liquid nitrogen for storage. Period of vitrification of blastocysts using conventional 0.25 mL straw was from May 2000 to March 2005 and its of PNC method was from April 2005 to December 2011. One to three embryos or blastocysts were loaded into each container.

5. Warming of vitrified embryos
-------------------------------

For the PNC protocol, embryos were warmed by holding the container with bare hands (33℃ to 34℃) for 5 seconds. For the traditional protocol, straws were warmed in a 22℃ water bath for 10 seconds. The post-warming steps were the same for both container types: the thawed embryos were sequentially transferred to a 1 M sucrose solution for 1 minutes (37℃), then to a 0.5 M sucrose solution for 3 minutes (25℃) and finally to 10% (v/v) SSS in PBS for 10 minutes (25℃). The survival of vitrified embryos following warming was evaluated on the basis of the re-expansion, transparency and shape of the cytoplasm after 18 to 24 hours.

6. AH with acidified medium
---------------------------

Cultured embryos underwent hatching in response to acidified medium delivered with a hatching micropipette after vitrification-warming procedures. AH was selectively performed on embryos with a poor prognosis (thick zona pellucida: \>15 µm, a retarded developmental rate and excessive fragmentation), or which showed low response for controlled ovarian hyperstimulation and had previously failed two or more IVF attempts.

Egg-holding and AH micropipettes were obtained from Humagen Fertility Diagnostics, Inc. (Charlottesville, VA, USA). During AH, embryos were rinsed and placed onto 0.1 mL droplets of modified HTF Medium HEPES (Irvine Scientific) supplemented with 10% (v/v) SSS. Acidified Tyrode\'s solution (Irvine Scientific) was then used to generate an opening of approximately 10 to 15 µm in diameter in the zona pellucida as previously described \[[@B14]\]. Embryos were then rinsed and placed in an embryo transfer dish containing 50 µL droplets of G2 media.

7. Assessment of embryo survival and the success of embryo transfer and pregnancy
---------------------------------------------------------------------------------

Approximately 17 to 18 hours after warming, the morphology and blastocoel expansion of embryos was assessed using a dissecting microscope. Only expanded blastocysts with an intact inner cell mass and trophectoderm and embryos which looked morphologically normal were judged to have survived. Female patients were administered transdermal E2 (Estrana, 0.4 mg/day; Hisamitsu, Tokyo, Japan) with GnRH agonists for preparation of the endometrium. Progesterone was administered (50 mg in oil, daily) when the endometrial thickness reached 8 mm. Two or three surviving blastocysts were transferred into uterus after 6 days of progesterone treatment and 3 to 5 cleaved embryos were transferred into the uterus after 4 days of progesterone treatment. Pregnancy was initially assessed by measuring serum hCG levels 14 days after embryo and blastocyst transfer. Clinical pregnancy was confirmed by the presence of fetal heart activity 30 days after embryo transfer using ultrasonography.

8. Statistical analysis
-----------------------

Data were statistically analyzed using the generalized linear model of the Statistical Analysis System (SPSS ver. 17.0, SPSS Inc., Chicago, IL, USA), analysis of variance and chi-square test. Significance was determined using a Tukey\'s multiple range test and *P*\<0.05 was considered significant.

Results
=======

In [Table 1](#T1){ref-type="table"}, data was collected from a total of 120 patients undergoing 117 treatment cycles (6 blastocysts of 3 cycles in straw group represented severely lysed. Therefore, embryo transfer of 3 cycles in straw group was not conducted) consisting of 27 cycles using blastocyst vitrification with a conventional straw (straw-BL group); 12 cycles using blastocyst vitrification with PNC (PNC-BL group); and 78 cycles using cleaved embryo vitrification with PNC (PNC-CL group). The mean maternal age for straw-BL was 31.3±3.8 years (range, 24 to 38 years).

The number of vitrified blastocysts in the straw-BL and PNC groups was 88 and 41, respectively. The number of vitrified cleaved embryos was 518. The recovery rates of embryos from each of the groups were 100%. The survival rates of embryos after warming from straw-BL, PNC-BL, and PNC-CL groups were 71.6%, 75.6% and 61% respectively. However, in the case of including survival rate of partial lysed embryos (35.3%) in PNC-CL group, the survival rate was 96.3%. The pregnancy rate of the PNC-BL group (75%) was no statically different than that of the straw-BL (44.4%) and the PNC-CL (47.4%) groups.

AH treatment was performed on poor quality blastocysts and cleaved embryos that exhibited zona hardening and/or partial lysis after vitrification during their development. Embryos were separated into two groups termed no-AH (good quality embryos without assisted hatching) and AH (poor quality embryos with assisted hatching). The survival rates of AH and no AH treated in all groups were not statically different ([Table 2](#T2){ref-type="table"}).

A comparison of the rates of survival after warming and the rates of clinical pregnancy between the AH and no-AH groups in blastocysts and cleaved embryos was performed ([Table 2](#T2){ref-type="table"}). Since AH treatment was only performed on poor quality cleaved embryos, the developmental rate of no-AH embryos was significantly higher than that of AH embryos in the cleaved embryo group (69.5% and 55.8%, respectively) with a lower rate of partial lysis (26.4% and 40.8%, respectively). No significant difference in the rate of clinical or ongoing pregnancy was observed between the no-AH blastocyst group and the AH blastocyst group. Additionally, we observed no significant difference in the rate of clinical or ongoing pregnancy between the no-AH cleaved embryo group and the AH cleaved embryo group (43% and 50%, respectively) using PNC method. This result indicates that AH treatment of poor quality (partial lysed) embryos may raise pregnancy rate to a similar level of that obtained with untreated good quality embryos.

Discussion
==========

Our results show that the pregnancy rate was not different in the PNC-BL group and straw-BL group. The PNC container was designed to reduce the volume of cryoprotectant needed and to simplify the vitrification procedure. We found that this container successfully cryopreserved both cleaved embryos and blastocysts. The PNC device can be easily constructed in the laboratory at a significantly lower cost (approximately \$0.5 \[USD\] per device) than commercial kits (cryoloops cost approximately \$20 \[USD\] per container). Furthermore, the PNC has a fast cooling speed with a small volume of loaded solution. The cooling rate in a 0.25 mL straw is 2,000℃/min \[[@B15]\]. However, the cooling rate of cut standard straw (CSS), original form of PNC, is calculated to be \>20,000℃/min and also yields high oocyte survival rates after warming \[[@B3]\]. Although we did not measured the cooling speed of PNC, the PNC container has a thinner wall than the original CSS container and contains less vitrification solution, meaning the cooling speed of PNC may be faster than that of CSS. An increase in the rate of cooling may help reduce freezing damage and the cryoprotectant concentration, resulting in a higher survival rate after warming and an increase in the clinical pregnancy rate. The clinical outcomes resulting from the transfer of cleaved embryos and blastocysts vitrified using PNC were comparable to those of embryos vitrified using other methods \[[@B16],[@B17]\]. Therefore, PNC may be the most cost-efficient and easily available vitrification method for embryos at various developmental stages.

Although there have been dramatic developments in IVF and ICSI techniques, some euploid embryos with full developmental potential still fail to implant due to hatching difficulties \[[@B18]\]. Spatially, in frozen-warmed embryos, cryopreservation and/or the freeze.warm process is thought to induce alterations in the glycoprotein matrix, which results in zona hardening \[[@B19]\]. Although AH has been developed to improve the rate of implantation of cryopreserved embryos, the benefits of AH are still debatable. To study the effects of AH, we investigated the rates of embryo survival, partial lysis and pregnancy in AH and no-AH groups. In [Table 2](#T2){ref-type="table"}, AH was performed on 356 poor quality cleaved embryos and blastocysts. We compared the survival and pregnancy rates of blastocysts and cleaved embryos in AH and no-AH groups. Warming did not result in a significant difference in the survival rates between AH blastoctyes and no-AH blastocytes ([Table 2](#T2){ref-type="table"}). When blastocyst vitrification was performed, the clinical pregnancy rate of the no-AH group was not different from that of the AH group. It is well studied that survival and clinical pregnancy rates of partial lysed embryos were inferior than that of fresh and normal embryo \[[@B8],[@B11]\]. However, in our study, AH treatment of poor quality embryos such as partial lysed embryos increased the pregnancy rate to a similar level of good quality embryo group (no-AH) ([Table 2](#T2){ref-type="table"}).

There are several explanations for the beneficial effects of AH on pregnancy rates. Firstly, AH may help synchronize the implantation window, a critical period during which the endometrium is ideal for implantation, with embryo hatching. Ideally, embryo hatching and the implantation window should coincide to maximize successful implantation \[[@B20]\]. Weakening within the zona pellucida may lead to embryos hatching earlier than normal, which could allow embryos to contact the endometrium before the implantation window \[[@B21]\]. Secondly, many molecules can pass through the zona pellucida and it is possible that AH treatment facilitates this movement. The thickness of the zona may affect the rate of transport of various molecules and nutrients such as growth factors. The presence of the artificial gap generated by AH treatment may facilitate the transport of metabolites and growth factors across the zona pellucida \[[@B6]\], which in turn may enhance embryo development and blastocyst formation \[[@B22]\]. Thirdly, blastocysts require a certain level of physical strength to hatch. A previous study reported that embryos with less physical strength, such as poorly developed and/or partial lysed embryos, are unable to overcome the rigidity of the zona pellucida and often fail to implant \[[@B23]\]. Artificial thinning or opening of the zona pellucida at an earlier developmental stage, or lysis of embryos due to physical damage, might increase the incidence of hatching \[[@B13],[@B24]\]. AH treatment, which reduces the rigidity of the zona pellucida, may also help overcome this barrier and thereby improve the rate of hatching. In conclusion, selective AH treatment of poor quality embryos may significantly increase the hatching rate by synchronizing hatching with the implantation window; by assisting embryo development via facilitation of the passage of molecules and nutrients across the zona pellucida; and by reducing the rigidity of the zona pellucida via the introduction of artificial gaps.

Our results suggest that PNC is a simple and inexpensive procedure that can increase the number of clinical pregnancies via the vitrification of blastocysts. In addition, selective AH treatment of embryos that show a poor prognosis after warming may increase the rate of clinical pregnancy.
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![Vitrification-warming of embryos using the modified cut standard straw (PNC) method and structure of conventional straw. (A) Day 3 human cleaved embryos (×40). (B) Shape of the PNC (×40). (C) Loaded embryos on the tip of the PNC with a minimum volume of vitrification solution (×40). (D) Warming of embryos in the PNC by holding the PNC with bare hands (×40). (E) Cultured embryos for 42 hours after warming (arrows indicate partial lysed cell) (×40). (F) Hatching embryos cultured for 66 hours after warming and assisted hatching (arrows indicate partially lysed cells) (×40). (G) Structure of conventional straw for embryo vitrification (VS, vitrification solution; S, sucrose) (×40).](ogs-56-182-g001){#F1}
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Vitrification-warming of cleaved embryos and blastocysts using conventional straw and PNC
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PNC, pull and cut straw; Straw-BL, blastocyst vitrification with a conventional straw; PNC-BL, blastocyst vitrification with PNC; PNC-CL, cleaved embryo vitrification with PNC; SD, standard deviation; IE, intact embryos; PL, partial lysed; ET, embryo transfer.

Values with different superscripts (^a)^ and ^b)^) differ significantly (*P* \< 0.05).
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Survival and pregnancy rates of AH and no-AH treated embryos after vitrification-warming using conventional straw and PNC
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Although 88 blastocysts of 30 cycles in straw-BL was vitrified and warmed, 6 blastocysts of 3 cycles represented severely lysed. Therefore, 6 severely lysed blastocysts were not transferred.

AH, assisted hatching; PNC, pull and cut straw; Straw-BL, blastocyst vitrification with a conventional straw; PNC-BL, blastocyst vitrification with PNC; PNC-CL, cleaved embryo vitrification with PNC; SD, standard deviation; IE, intact embryos; PL, partial lysed; ET, embryo transfer.

Values with different superscripts (^a)^) differ significantly (*P* \< 0.05).
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